Trial Profile
A Study Assessing Therapeutic Efficacy of Nimotuzumab Combined with Concurrent Chemoradiotherapy in Treatment of Locally Advanced Cervical Cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Jun 2017
Price :
$35
*
At a glance
- Drugs Nimotuzumab (Primary)
- Indications Cervical cancer
- Focus Adverse reactions; Therapeutic Use
- 13 Jun 2017 New trial record
- 06 Jun 2017 Results presented at the 53rd Annual Meeting of the American Society of Clinical Oncology.